Bayesian Approach to Utilize Historical Control Data in Clinical Trials

武田健太朗∗1,∗2・大庭真梨∗1・柿爪智行∗3・坂巻顕太郎∗1・ 田栗正隆∗1・森田智視∗1,∗4 Kentaro Takeda∗1,∗2, Mari Oba∗1, Tomoyuki Kakizume∗3, Kentaro Sakamaki∗1 , Masataka Taguri∗1 and Satoshi Morita∗1,∗4 ∗1横浜市立大学大学院医学研究科 臨床統計学・疫学 ∗2アステラス製薬株式会社 開発本部 データサイエンス部 ∗3ノバルティスファーマ株式会社 オンコロジー開発統括部 オンコロジー生物統計・DM部 ∗4京都大学大学院医学研究科 医学統計生物情報学 ∗1Department of Biostatistics and Epidemiology, Yokohama City University Graduate School of Medicine ∗2Biostatistics Group, Data Science, Global Development, Astellas Pharma Inc. ∗3Oncology Biostatistics Group, Oncology Biometrics and Data Management Department, Novartis Pharma K.K. ∗4Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine e-mail:kentaro.takeda@astellas.com

[1]  Joseph G. Ibrahim,et al.  The relationship between the power prior and hierarchical models , 2006 .

[2]  J. Ibrahim,et al.  Power prior distributions for regression models , 2000 .

[3]  D. Rubin,et al.  The central role of the propensity score in observational studies for causal effects , 1983 .

[4]  D J Spiegelhalter,et al.  Bayesian methods for cluster randomized trials with continuous responses. , 2001, Statistics in medicine.

[5]  Karel G M Moons,et al.  Incorporation of historical data in the analysis of randomized therapeutic trials. , 2011, Contemporary clinical trials.

[6]  Brian P Hobbs,et al.  Adaptive adjustment of the randomization ratio using historical control data , 2013, Clinical trials.

[7]  Anthony O'Hagan,et al.  Robust meta‐analytic‐predictive priors in clinical trials with historical control information , 2014, Biometrics.

[8]  D. Schoenfeld,et al.  Bayesian design using adult data to augment pediatric trials , 2009, Clinical trials.

[9]  Bradley P Carlin,et al.  Hierarchical Commensurate and Power Prior Models for Adaptive Incorporation of Historical Information in Clinical Trials , 2011, Biometrics.

[10]  Michael Branson,et al.  A note on the power prior , 2009, Statistics in medicine.

[11]  Satoshi Morita,et al.  Prior Effective Sample Size in Conditionally Independent Hierarchical Models. , 2012, Bayesian analysis.

[12]  Keying Ye,et al.  Using power priors to improve the binomial test of water quality , 2006 .

[13]  S J Pocock,et al.  The combination of randomized and historical controls in clinical trials. , 1976, Journal of chronic diseases.

[14]  S. Morita,et al.  Incorporating Historical Data in Bayesian Phase I Trial Design: The Caucasian-to-Asian Toxicity Tolerability Problem , 2015, Therapeutic innovation & regulatory science.

[15]  K. Moons,et al.  A randomised clinical trial on cardiotocography plus fetal blood sampling versus cardiotocography plus ST-analysis of the fetal electrocardiogram (STAN®) for intrapartum monitoring , 2007, BMC pregnancy and childbirth.

[16]  Keying Ye,et al.  Evaluating water quality using power priors to incorporate historical information , 2006 .

[17]  David R. Jones,et al.  How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS , 2005, Statistics in medicine.

[18]  Byron J Gajewski.  Comments on 'A note on the power prior' by Neuenschwander B, Branson M and Spiegelhalter DJ. Statistics in Medicine; DOI: 10.1002/sim.3722. , 2010, Statistics in medicine.

[19]  D. Spiegelhalter,et al.  Summarizing historical information on controls in clinical trials , 2010, Clinical trials.

[20]  David J Spiegelhalter,et al.  Bias modelling in evidence synthesis , 2009, Journal of the Royal Statistical Society. Series A,.

[21]  Xuefeng Li,et al.  Bayesian Approaches in Medical Device Clinical Trials: A Discussion with Examples in the Regulatory Setting , 2011, Journal of biopharmaceutical statistics.

[22]  M. Cantor,et al.  Creation and implementation of a historical controls database from randomized clinical trials. , 2013, Journal of the American Medical Informatics Association : JAMIA.

[23]  Fang Chen,et al.  Use of historical control data for assessing treatment effects in clinical trials , 2014, Pharmaceutical statistics.

[24]  KyungMann Kim,et al.  Contrasting treatment‐specific survival using double‐robust estimators , 2012 .

[25]  Scott M Berry,et al.  Recent Statistical Contributions to Medical Device Development , 2014, Therapeutic innovation & regulatory science.

[26]  W. J. Boscardin,et al.  Effect of Supersaturated Oxygen Delivery on Infarct Size After Percutaneous Coronary Intervention in Acute Myocardial Infarction , 2009, Circulation. Cardiovascular interventions.

[27]  K. Maršál,et al.  Cardiotocography only versus cardiotocography plus ST analysis of fetal electrocardiogram for intrapartum fetal monitoring: a Swedish randomised controlled trial , 2001, The Lancet.

[28]  Heinz Schmidli,et al.  Using historical control information for the design and analysis of clinical trials with overdispersed count data , 2013, Statistics in medicine.

[29]  Diane D. Liu,et al.  Bayesian clinical trials at the University of Texas M. D. Anderson Cancer Center , 2009, Clinical trials.

[30]  Gene Pennello,et al.  Experience with Reviewing Bayesian Medical Device Trials , 2007, Journal of biopharmaceutical statistics.

[31]  P. Müller,et al.  Determining the Effective Sample Size of a Parametric Prior , 2008, Biometrics.

[32]  D. Spiegelhalter,et al.  Bayesian Approaches to Clinical Trials and Health-Care Evaluation: Spiegelhalter/Clinical Trials and Health-Care Evaluation , 2004 .

[33]  Gregory Campbell,et al.  Bayesian Statistics in Medical Devices: Innovation Sparked by the FDA , 2011, Journal of biopharmaceutical statistics.

[34]  Marc Vandemeulebroecke,et al.  Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial , 2012, Gut.

[35]  R. Cuffe.  The inclusion of historical control data may reduce the power of a confirmatory study , 2011, Statistics in medicine.

[36]  Andrew Thomas,et al.  The BUGS project: Evolution, critique and future directions , 2009, Statistics in medicine.

[37]  A. Gelman.  Prior distributions for variance parameters in hierarchical models (comment on article by Browne and Draper) , 2004 .

[38]  L. Wasserman,et al.  The Selection of Prior Distributions by Formal Rules , 1996 .

[39]  J. Westgate,et al.  Plymouth randomized trial of cardiotocogram only versus ST waveform plus cardiotocogram for intrapartum monitoring in 2400 cases. , 1993, American journal of obstetrics and gynecology.

[40]  Brian Neelon,et al.  Bayesian Analysis Using Power Priors with Application to Pediatric Quality of Care , 2010 .

[41]  Bradley P Carlin,et al.  Commensurate Priors for Incorporating Historical Information in Clinical Trials Using General and Generalized Linear Models. , 2012, Bayesian analysis.

[42]  M. Vääräsmäki,et al.  A comparison of intrapartum automated fetal electrocardiography and conventional cardiotocography—a randomised controlled study , 2006, BJOG : an international journal of obstetrics and gynaecology.

[43]  Joseph G Ibrahim,et al.  Bayesian methods in clinical trials: a Bayesian analysis of ECOG trials E1684 and E1690 , 2012, BMC Medical Research Methodology.

[44]  武田純.  MCMCプロシジャを用いたNormalized Power Priorの実用的な実装 , 2014, SAS 2014.